Novel azasulfuryl-containing peptidomimetics capable of inhibiting CD36 activity are disclosed. Use of these azasulfuryl-containing peptidomimetics for the treatment of CD36-related diseases, disorders or conditions, including TLR2-mediated inflammatory disease, disorder or condition, and methods of obtaining such azasulfuryl-containing peptidomimetics, are also disclosed.
揭示了能够抑制CD36活性的新型含氮
硫酰基的肽类模拟物。还揭示了利用这些含氮
硫酰基的肽类模拟物治疗与CD36相关的疾病、紊乱或状况,包括TLR2介导的炎症性疾病、紊乱或状况的用途,以及获取这种含氮
硫酰基的肽类模拟物的方法。